BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 27374224)

  • 21. Granulocyte-Macrophage Colony-Stimulating Factor-Activated Neutrophils Express B7-H4 That Correlates with Gastric Cancer Progression and Poor Patient Survival.
    Shan ZG; Yan ZB; Peng LS; Cheng P; Teng YS; Mao FY; Fan K; Zhuang Y; Zhao YL
    J Immunol Res; 2021; 2021():6613247. PubMed ID: 33763491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-gamma inhibits tumor antigen presentation by epidermal antigen-presenting cells.
    Grabbe S; Bruvers S; Beissert S; Granstein RD
    J Leukoc Biol; 1994 Jun; 55(6):695-701. PubMed ID: 8195694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocyte colony-stimulating factor impairs CD8(+) T cell functionality by interfering with central activation elements.
    Bunse CE; Tischer S; Lahrberg J; Oelke M; Figueiredo C; Blasczyk R; Eiz-Vesper B
    Clin Exp Immunol; 2016 Jul; 185(1):107-18. PubMed ID: 26990855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation.
    van Elsas A; Hurwitz AA; Allison JP
    J Exp Med; 1999 Aug; 190(3):355-66. PubMed ID: 10430624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-linking of human FcgammaRIIIb induces the production of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor by polymorphonuclear neutrophils.
    Durand V; Renaudineau Y; Pers JO; Youinou P; Jamin C
    J Immunol; 2001 Oct; 167(7):3996-4007. PubMed ID: 11564819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activated phenotype in neutrophils and monocytes from patients with primary proliferative polycythaemia.
    Westwood NB; Copson ER; Page LA; Mire-Sluis AR; Brown KA; Pearson TC
    J Clin Pathol; 1995 Jun; 48(6):525-30. PubMed ID: 7545186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional maturation of adult mouse resting microglia into an APC is promoted by granulocyte-macrophage colony-stimulating factor and interaction with Th1 cells.
    Aloisi F; De Simone R; Columba-Cabezas S; Penna G; Adorini L
    J Immunol; 2000 Feb; 164(4):1705-12. PubMed ID: 10657614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response.
    Gri G; Gallo E; Di Carlo E; Musiani P; Colombo MP
    J Immunol; 2003 Jan; 170(1):99-106. PubMed ID: 12496388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes.
    Gil-Lamaignere C; Simitsopoulou M; Roilides E; Maloukou A; Winn RM; Walsh TJ
    J Infect Dis; 2005 Apr; 191(7):1180-7. PubMed ID: 15747255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophil granulocyte-committed cells can be driven to acquire dendritic cell characteristics.
    Oehler L; Majdic O; Pickl WF; Stöckl J; Riedl E; Drach J; Rappersberger K; Geissler K; Knapp W
    J Exp Med; 1998 Apr; 187(7):1019-28. PubMed ID: 9529318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced PMN beta 2 integrins after trauma: a possible role for colony-stimulating factors.
    White-Owen C; Hartmann S; Alexander JW; Babcock GF
    Clin Exp Immunol; 1993 Jun; 92(3):477-81. PubMed ID: 7685673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages.
    O'Mahony DS; Pham U; Iyer R; Hawn TR; Liles WC
    Int J Med Sci; 2008 Jan; 5(1):1-8. PubMed ID: 18219369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophils activated by granulocyte-macrophage colony-stimulating factor express receptors for interleukin-3 which mediate class II expression.
    Smith WB; Guida L; Sun Q; Korpelainen EI; van den Heuvel C; Gillis D; Hawrylowicz CM; Vadas MA; Lopez AF
    Blood; 1995 Nov; 86(10):3938-44. PubMed ID: 7579364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression.
    Queen MM; Ryan RE; Holzer RG; Keller-Peck CR; Jorcyk CL
    Cancer Res; 2005 Oct; 65(19):8896-904. PubMed ID: 16204061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influenza-infected neutrophils within the infected lungs act as antigen presenting cells for anti-viral CD8(+) T cells.
    Hufford MM; Richardson G; Zhou H; Manicassamy B; García-Sastre A; Enelow RI; Braciale TJ
    PLoS One; 2012; 7(10):e46581. PubMed ID: 23056353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma.
    Wislez M; Fleury-Feith J; Rabbe N; Moreau J; Cesari D; Milleron B; Mayaud C; Antoine M; Soler P; Cadranel J
    Am J Pathol; 2001 Oct; 159(4):1423-33. PubMed ID: 11583970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Origins of tumor-associated macrophages and neutrophils.
    Cortez-Retamozo V; Etzrodt M; Newton A; Rauch PJ; Chudnovskiy A; Berger C; Ryan RJ; Iwamoto Y; Marinelli B; Gorbatov R; Forghani R; Novobrantseva TI; Koteliansky V; Figueiredo JL; Chen JW; Anderson DG; Nahrendorf M; Swirski FK; Weissleder R; Pittet MJ
    Proc Natl Acad Sci U S A; 2012 Feb; 109(7):2491-6. PubMed ID: 22308361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocyte-macrophage colony-stimulating factor induces neutrophil adhesion to pulmonary vascular endothelium in vivo: role of beta 2 integrins.
    Yong KL; Rowles PM; Patterson KG; Linch DC
    Blood; 1992 Sep; 80(6):1565-75. PubMed ID: 1355672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.
    Huang AY; Golumbek P; Ahmadzadeh M; Jaffee E; Pardoll D; Levitsky H
    Science; 1994 May; 264(5161):961-5. PubMed ID: 7513904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.
    Hurwitz AA; Yu TF; Leach DR; Allison JP
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10067-71. PubMed ID: 9707601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.